111 related articles for article (PubMed ID: 27601312)
1. Striking dyserythropoiesis in a myelodysplastic syndrome.
Siow W; May PC; Haji R; Gabriel I; Bain BJ
Am J Hematol; 2017 Feb; 92(2):218. PubMed ID: 27601312
[No Abstract] [Full Text] [Related]
2. Proposal of criteria for dyserythropoiesis in the diagnosis of myelodysplastic syndromes.
Kawai N; Matsuda A; Jinnai I; Ichimura T; Kayano H; Okamura D; Ishikawa M; Maeda T; Hata T; Miyazaki Y; Asou N; Bessho M; Tomonaga M
Int J Hematol; 2016 Feb; 103(2):227-33. PubMed ID: 26608365
[TBL] [Abstract][Full Text] [Related]
3. Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome.
Narukawa K; Masuda A; Takahashi T
Int J Hematol; 2021 Jun; 113(6):775-776. PubMed ID: 33864622
[No Abstract] [Full Text] [Related]
4. Dyserythropoiesis of myelodysplastic syndromes.
Lefèvre C; Bondu S; Le Goff S; Kosmider O; Fontenay M
Curr Opin Hematol; 2017 May; 24(3):191-197. PubMed ID: 28072603
[TBL] [Abstract][Full Text] [Related]
5. Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics.
Rosenberg CA; Bill M; Rodrigues MA; Hauerslev M; Kerndrup GB; Hokland P; Ludvigsen M
Cytometry B Clin Cytom; 2021 Sep; 100(5):554-567. PubMed ID: 33285035
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow biopsy in patients with hepatitis C virus infection: spectrum of findings and diagnostic utility.
Klco JM; Geng B; Brunt EM; Hassan A; Nguyen TD; Kreisel FH; Lisker-Melman M; Frater JL
Am J Hematol; 2010 Feb; 85(2):106-10. PubMed ID: 20095034
[TBL] [Abstract][Full Text] [Related]
7. Concomitant bone marrow involvement by plasma cell myeloma and primary myelodysplastic syndrome with biclonal complex chromosome anomalies.
Nanaji NM; Chen QC; Singh Z; Ross DD; Elman AH; Zou YS
Leuk Lymphoma; 2015; 56(8):2470-2. PubMed ID: 25586604
[No Abstract] [Full Text] [Related]
8. Impaired formation of erythroblastic islands is associated with erythroid failure and poor prognosis in a significant proportion of patients with myelodysplastic syndromes.
Buesche G; Teoman H; Giagounidis A; Göhring G; Schlegelberger B; Ganser A; Aul C; Kreipe HH
Haematologica; 2016 May; 101(5):e177-81. PubMed ID: 26944473
[No Abstract] [Full Text] [Related]
9. [Cytodynamics of myeloid precursors (divisible erythroblasts and granulocytes) in myelodysplastic syndromes].
Sánchez Fayos J; Outeiriño J; Calabuig T; Prieto E; Pérez-Sánchez I; Lapuente L; Escudero A
Sangre (Barc); 1985; 30(4-C):698-704. PubMed ID: 4089739
[No Abstract] [Full Text] [Related]
10. [The myelodysplastic syndrome: the problems of its pathogenesis and treatment].
Savchenko VG; Parovichnikova EN; Mikhaĭlova EA; Ol'shanskaia IuV; Ustinova EN; Gribanova EO; Frank GA; Tikhonova LIu; Kokhno AV; Obidina NA; Kuchma IuM
Ter Arkh; 1996; 68(7):31-7. PubMed ID: 8928069
[No Abstract] [Full Text] [Related]
11. Spurious dyserythropoiesis.
Wang LJ; Glasser L
Am J Clin Pathol; 2002 Jan; 117(1):57-9. PubMed ID: 11789731
[TBL] [Abstract][Full Text] [Related]
12. Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centre.
Huang H; Xu C; Gao J; Li B; Qin T; Xu Z; Ren S; Zhang Y; Jiao M; Qu S; Pan L; Hu N; Liu J; Cai W; Zhang Y; Wu D; Zhang P; Gale RP; Huang G; Zhou J; Shi L; Xiao Z
Blood Cancer J; 2020 Aug; 10(8):83. PubMed ID: 32801296
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in the myelodysplastic syndromes: a review.
Tricot G; Vlietinck R; Verwilghen RL
Scand J Haematol Suppl; 1986; 45():107-13. PubMed ID: 3515514
[No Abstract] [Full Text] [Related]
14. Chronic lymphocytic leukemia associated with myelodysplastic syndrome with ring sideroblasts.
Charafeddine KM; Ibrahim GY; Mahfouz RA; Zaatari GS; Salem ZM
South Med J; 2010 Aug; 103(8):823-7. PubMed ID: 20622728
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndrome associated with acquired beta thalassemia: "BTMDS".
Brunner AM; Steensma DP
Am J Hematol; 2016 Aug; 91(8):E325-7. PubMed ID: 27121565
[TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic syndrome with excess blasts-2 associated with erythroid predominance.
Pourabdollah M; Chang H
Blood; 2017 Feb; 129(7):918. PubMed ID: 28209754
[No Abstract] [Full Text] [Related]
17. Copper deficiency: a cause of misdiagnosis of myelodysplastic syndrome.
Villalba A; Osorio J; Freiria C; Santiago M; Boluda B; Vicente AI; Sempere A; Andreu R; Gomis F; Senent L
Ann Hematol; 2018 Sep; 97(9):1737-1738. PubMed ID: 29663030
[No Abstract] [Full Text] [Related]
18. Megaloblastic Anemia with Ring Sideroblasts is not Always Myelodysplastic Syndrome.
Narang NC; Kotru M; Rao K; Sikka M
Turk J Haematol; 2016 Dec; 33(4):358-359. PubMed ID: 27466740
[No Abstract] [Full Text] [Related]
19. Significance of the ratio of reticulocyte subpopulations in bone marrow and peripheral blood from patients with myelodysplastic syndromes.
Choi JW; Pai SH; Choe HW
Ann Hematol; 2003 Apr; 82(4):259-61. PubMed ID: 12707734
[No Abstract] [Full Text] [Related]
20. Diagnostic approach to the myelodysplastic syndromes.
Cazzola M; Ponchio L; Rosti V; Farina G; Pedrotti C; Bergamaschi G
Leukemia; 1992 Nov; 6 Suppl 4():19-22. PubMed ID: 1434825
[No Abstract] [Full Text] [Related]
[Next] [New Search]
